Abstract:<h3 class="a-plus-plus">Abstract</h3> <p class="a-plus-plus">Over the last two decades, mass spectrometry imaging (MSI) has been increasingly employed to investigate the spatial distribution of a wide variety of molecules in complex biological samples. MSI has demonstrated its potential in numerous applications from drug discovery, disease state evaluation through proteomic and/or metabolomic studies. Significant technological and methodological advancements have addressed natural limitations of the techniques, <em class="a-plus-plus">i.e.</em>, increased spatial resolution, increased detection sensitivity especially for large molecules, higher throughput analysis and data management. One of the next major evolutions of MSI is linked to the introduction of imaging mass cytometry (IMC). IMC is a multiplexed method for tissue phenotyping, imaging signalling pathway or cell marker assessment, at sub-cellular resolution (1 μm). It uses MSI to simultaneously detect and quantify up to 30 different antibodies within a tissue section. The combination of MSI with other molecular imaging techniques can also provide highly relevant complementary information to explore new scientific fields. Traditionally, classical histology (especially haematoxylin and eosin–stained sections) is overlaid with molecular profiles obtained by MSI. Thus, MSI-based molecular histology provides a snapshot of a tissue microenvironment and enables the correlation of drugs, metabolites, lipids, peptides or proteins with histological/pathological features or tissue substructures. Recently, many examples combining MSI with other imaging modalities such as fluorescence, confocal Raman spectroscopy and MRI have emerged. For instance, brain pathophysiology has been studied using both MRI and MSI, establishing correlations between in and <em class="a-plus-plus">ex vivo</em> molecular imaging techniques. Endogenous metabolite and small peptide modulation were evaluated depending on disease state. Here, we review advanced ‘hot topics’ in MSI development and explore the combination of MSI with established molecular imaging techniques to improve our understanding of biological and pathophysiological processes.</p>

New perspective on central nervous system disorders: focus on mass spectrometry imaging

Progress Of Mass Spectrometry Imaging In Neuroscience

Mass Spectrometry Imaging as a New Method: To Reveal the Pathogenesis and the Mechanism of Traditional Medicine in Cerebral Ischemia

Spatial neurolipidomics—MALDI mass spectrometry imaging of lipids in brain pathologies

Novel imaging and related techniques for studies of diseases of the central nervous system: a review

Molecular Imaging in Traditional Chinese Medicine Therapy for Neurological Diseases.

A new direction in metabolomics: Analysis of the central nervous system based on spatially resolved metabolomics

Mass spectrometry for biomarkers, disease mechanisms, and drug development in cerebrospinal fluid metabolomics

Mass Spectrometry Imaging and Integration with Other Imaging Modalities for Greater Molecular Understanding of Biological Tissues

Multimodal Magnetic Resonance Imaging for Brain Disorders: Advances and Perspectives

Advances in Proteomics Allow Insights Into Neuronal Proteomes

PET/MRI of Central Nervous System: Current Status and Future Perspective

Molecular network strategy in multi-omics and mass spectrometry imaging

Mapping Metabolic Networks in the Brain by Ambient Mass Spectrometry Imaging and Metabolomics

Next Generation of Mass Spectrometry Imaging: from Micrometer to Subcellular Resolution

Mass spectrometry imaging: new eyes on natural products for drug research and development

Next-generation pathology practices with mass spectrometry imaging

Application of functional proteomics in neurological disorders

Recent Advances in Mass Spectrometry Imaging Combined with Artificial Intelligence for Spatially Clarifying Molecular Profiles: Toward Biomedical Applications

Advances in nanomedicines for diagnosis of central nervous system disorders

Structural and Functional Imaging of Brains